NOTE: This order is nonprecedential. United States Court of Appeals
for the Federal Circuit EXELTIS USA, INC., LABORATORIOS LEON
FARMA, S.A., CHEMO IBERICA, S.A., CHEMO
RESEARCH, S.L.,
Plaintiffs-Appellees
v.
LUPIN LTD., LUPIN PHARMACEUTICALS, INC.,
Defendants-Appellants
2025-1239
Appeal from the United States District Court for the District of Delaware in No. 1:22-cv-00434-RGA, Judge Richard G. Andrews.
ON MOTION
Before LOURIE, PROST, and CHEN, Circuit Judges.
O R D E R
The parties notify the court that they have executed a settlement agreement resolving all claims and move at ECF Nos. 23 and 24 for dismissal of this appeal and2 2 EXELTIS USA, INC. v. LUPIN LTD.
remand to the district court to amend the judgment consistent with its August 29, 2025 indicative ruling. Upon consideration thereof, IT IS ORDERED THAT:
(1) The motions are granted to the extent that the appeal is remanded to the district court to rule on the parties’ motion to amend the final judgment, which this court leaves to the district court. See Ohio Willow Wood Co. v. Thermo-Ply, Inc., 629 F.3d 1374, 1375 (Fed. Cir. 2011). (2) The parties shall bear their own costs.
FOR THE COURT
September 29, 2025 Date ISSUED AS A MANDATE: September 29, 2025